News

Evidence Doesn't Support High-Dose Vitamin D Intake

Publish date: June 1, 2011
PDF Download

 

Expert Analysis from the Congress of Clinical Rheumatology

Dr. Manson has received funding from the National Institutes of Health to conduct a large-scale randomized trial of vitamin D and omega-3 fatty acids.

Pages

Recommended Reading

Women on Denosumab Maintain Bone Benefits After 5 Years
MDedge Endocrinology
Atypical Fracture Risk Low for Bisphosphonates
MDedge Endocrinology
Denosumab's Bone Benefits Persist at 5 Years of Therapy
MDedge Endocrinology
New Guidance Aids Osteoporosis Screening
MDedge Endocrinology
Denosumab Gains New Indication, for Bone Metastases
MDedge Endocrinology
Local Corticosteroids Slowed RA Hand Bone Loss
MDedge Endocrinology
Nitroglycerin Ointment Strengthened Bone
MDedge Endocrinology
Zoledronic Acid Cuts Fractures at All Risk Levels
MDedge Endocrinology
Atypical Fractures Rare With Bisphosphonates
MDedge Endocrinology
Denosumab Curbs Fractures Equally at All Risk Levels
MDedge Endocrinology